Breaking News Instant updates and real-time market news.

UBS

UBS

$14.03

0.2 (1.45%)

, PH

Parker-Hannifin

$126.55

2.9 (2.35%)

10:16
10/05/16
10/05
10:16
10/05/16
10:16

On The Fly: Top five analyst upgrades

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. UBS (UBS) upgraded to Sector Perform from Underperform at RBC Capital with analyst Fiona Swaffield saying she sees a dividend reduction as unlikely and believes expectations for the bank's Wealth Management business are now lower. 2. Parker-Hannifin (PH) upgraded to Buy from Hold at Stifel with analyst Nathan Jones saying distributors expect to see revenue growth declining 2% in the second quarter of fiscal 2017 which he believes should be enough for Parker to see its first positive year-over-year revenue comp company wide in six quarters. 3. Flex (FLEX) upgraded to Conviction Buy from Buy at Goldman with analyst Mark Delaney saying it is positioned to benefit from entry into new markets and valuation looks attractive. 4. KBR (KBR) upgraded to Accumulate from Hold at Johnson Rice with analyst Martin Malloy citing the recent pullback in shares and said the stock multiple should trend higher given the shift in business mix to more low-risk, cost reimbursement revenues. 5. Plains All American (PAA) upgraded to Outperform from Market Perform at Wells Fargo. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

UBS

UBS

$14.03

0.2 (1.45%)

PH

Parker-Hannifin

$126.55

2.9 (2.35%)

FLEX

Flex

$13.62

0.05 (0.37%)

KBR

KBR

$14.51

0.41 (2.91%)

PAA

Plains All American

$31.63

0.973 (3.17%)

  • 27

    Oct

  • 03

    Nov

  • 14

    Nov

UBS UBS
$14.03

0.2 (1.45%)

10/05/16
RBCM
10/05/16
UPGRADE
RBCM
Sector Perform
UBS upgraded to Sector Perform from Underperform at RBC Capital
RBC Capital analyst Fiona Swaffield upgraded UBS to Sector Perform with a price target of CHF 14. The analyst sees a dividend reduction as unlikely and believes expectations for the bank's Wealth Management business are now lower.
09/19/16
09/19/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. DSW (DSW) initiated with a Negative at Susquehanna. 2. Deutsche Bank (DB) initiated with an Underperform at Credit Suisse. 3. UBS (UBS) initiated with a Neutral at Credit Suisse. 4. Cerner (CERN) initiated with a Neutral at BofA/Merrill. 5. Callidus Software (CALD) reinstated with an Outperform at Credit Suisse. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/19/16
FBCO
09/19/16
INITIATION
FBCO
Neutral
UBS initiated with a Neutral at Credit Suisse
Credit Suisse analyst Jon Peace initiated UBS with a Neutral citing likely margin pressures and the need to build capital ratios.
07/11/16
BERN
07/11/16
INITIATION
Target $8.16
BERN
Underperform
UBS initiated with an Underperform at Bernstein
Target $8.16.
PH Parker-Hannifin
$126.55

2.9 (2.35%)

06/30/16
WELS
06/30/16
UPGRADE
WELS
Outperform
Parker-Hannifin upgraded to Outperform from Market Perform at Wells Fargo
Wells Fargo analyst Andrew Casey upgraded Parker-Hannifin to Outperform citing the recent pullback in shares, low investor expectations and positive fluid power distributor channel checks. The analyst keeps a $117-$120 price target range for the shares.
06/30/16
06/30/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on the today's top five analyst upgrades with this list compiled by The Fly: 1. Priceline (PCLN) upgraded to Overweight from Equal Weight at Morgan Stanley by analysts led by Brian Nowak, who raised his price target to $1,525 from $1,330. The analyst sees improving ad efficiency driving increased profitability and material market share gains in alt. accommodations. Nowak sees a more rational ad environment resulting in margin improvement and raised 2017 room nights by 2%, with alt. accommodations set to grow 34% 2015-2018 CAGR, driving bookings growth to 28.5%. 2. Motorola Solutions (MSI) upgraded to Buy from Neutral at Goldman by analyst Matthew Cabral after assuming primary coverage of the shares. The company's renewed focus on revenue growth and spending management is a positive shift in strategy, Cabral tells investors in a research note. He believes the shares at current levels offer a compelling entry point. Cabral raised his price target for Motorola Solutions to $81 from $74. The firm also upgraded Nokia (NOK) to Buy from Neutral. 3. Parker-Hannifin (PH) upgraded to Outperform from Market Perform at Wells Fargo by analyst Andrew Casey, citing the recent pullback in shares, low investor expectations and positive fluid power distributor channel checks. The analyst keeps a $117-$120 price target range for the shares. 4. Marriott (MAR) upgraded to Buy from Hold at Evercore ISI by analyst Rich Hightower, who trimmed his price target to $75 from $76. The analyst has now fully incorporated Starwood's (HOT) numbers into the model and said weakness following Brexit has created a buying opportunity. 5. Yamana Gold (AUY) upgraded to Outperform from Neutral at Credit Suisse by analyst Anita Soni, who raised her price target to $6.50 from $4.50 in conjunction with an increased gold price forecast. The firm has increased its gold price forecast to a peak of $1,500 in Q1 2017. The analyst also upgraded Silver Wheaton (SLW) to Outperform from Neutral and IAMGOLD (IAG) to Neutral from Sell. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/05/16
STFL
10/05/16
UPGRADE
STFL
Buy
Parker-Hannifin upgraded to Buy from Hold at Stifel
10/05/16
10/05/16
UPGRADE
Target $141

Buy
Parker-Hannifin upgraded to Buy on improved outlook at Stifel
As previously reported, Stifel upgraded Parker-Hannifin to Buy from Hold and established a $141 price target. Analyst Nathan Jones recent distributor survey results indicate Parker-Hannifin will beat Q1 North American revenue estimates. Jones said distributors expect to see revenue growth (2%) in Q2 FY17 which he believes should be enough for Parker to see its first positive year-over-year revenue comp company wide in 6 quarters. The analyst said consensus is currently forecasting a slightly negative Q2 top line comparison. which should help investors get comfortable that the worst of the current downturn is behind Parker.
FLEX Flex
$13.62

0.05 (0.37%)

05/12/16
BOFA
05/12/16
INITIATION
Target $15
BOFA
Buy
Flex reinstated with a Buy at BofA/Merrill
BofA/Merrill reinstated coverage on Flex with a Buy rating and $15 price target.
09/20/16
GSCO
09/20/16
UPGRADE
Target $16
GSCO
Buy
Flex upgraded to Buy from Neutral at Goldman
Goldman analyst Mark Delaney upgraded Flex (FLEX) to Buy and raised its price target to $16 from $13. The analyst said Flex is entering the footwear manufacturing market with its expanded partnership with Nike (NKE), nearly doubling its addressable market. Further the company has diversified its end market exposure and is now less reliant on traditional tech markets like handsets, the analyst wrote. Delaney adds that Flex trades at a discount to the group despite better growth and diversification.
10/05/16
GSCO
10/05/16
UPGRADE
Target $16
GSCO
Conviction Buy
Flex upgraded to Conviction Buy from Buy at Goldman
Goldman analyst Mark Delaney added Flex to the Conviction Buy List and maintained its $16 price target saying it is positioned to benefit from entry into new markets and valuation looks attractive. Delaney said new markets could nearly double Flex's TAM in soft goods manufacturing in the long-term, and Nike could develop into a top customers and drive margin expansion. Further, the company has an improving mix and shares trade at a discount to peers, the analyst wrote in a research note.
05/24/16
STPT
05/24/16
DOWNGRADE
STPT
Hold
Flex downgraded to Hold from Buy at Standpoint Research
KBR KBR
$14.51

0.41 (2.91%)

10/05/16
JRCO
10/05/16
UPGRADE
Target $18
JRCO
Accumulate
KBR upgraded to Accumulate from Hold at Johnson Rice
Johnson Rice analyst Martin Malloy upgraded KBR to Accumulate with an $18 price target citing the recent pullback in shares and said the stock multiple should trend higher given the shift in business mix to more low-risk, cost reimbursement revenues.
10/04/16
10/04/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. CBS (CBS) upgraded to Buy from Sell at UBS with analyst Doug Mitchelson saying he sees any deal with Viacom (VIA) as priced into CBS shares already. He also has increased confidence in consensus estimates for CBS and sees further upside if the national TV ad market and CBS' ratings remain strong. 2. Pandora (P) upgraded to Conviction Buy from Buy at Goldman with analyst Heath Terry saying he sees significant upside to out-year estimates from premium radio and on-demand subscriptions. He expects competition to ease as new entrants slow and existing providers focus on profitability and limit "free" models. 3. Las Vegas Sands (LVS) upgraded to Buy from Neutral at BofA/Merrill with analyst Shaun Kelley saying shares remain fairly under-owned and thinks estimate revisions will move higher due to market momentum, better ROI for Parisian, Cotai infrastructure additions, and optionality from Japan and real estate. 4. KBR (KBR) upgraded to Buy from Hold at Deutsche Bank with analyst Chad Dillard saying yesterday's 10% post-guidance cut selloff is overdone and backward-looking. 5. West Marine (WMAR) upgraded to Buy from Neutral at B. Riley. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/04/16
DBAB
10/04/16
UPGRADE
Target $16
DBAB
Buy
KBR upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst Chad Dillard upgraded KBR to Buy saying yesterday's 10% post-guidance cut selloff is overdone and backward-looking. The market is under-appreciating the company's transformation to a lower-risk government/technical services firm, Dillard tells investors in a research note. He upped his price target for KBR shares to $16 from $14.
09/27/16
DBAB
09/27/16
NO CHANGE
Target $14
DBAB
Hold
Deutsche sees 'realistic path' to KBR becoming $20-$25 stock
Deutsche Bank analyst Chad Dillard says he sees a "realistic path" towards KBR becoming a $20-$25 stock as the market beings to appreciate the company's transformation to a government/technical services company. The analyst, however, keeps a Hold rating on KBR with a $14 price target. The engineering and construction company closed yesterday up 10c to $14.50. Consensus estimates for 2017-2018 are too high and a reset in expectations could cause near-term price volatility, Dillard tells investors in a research note. He is "warming" to KBR's transformation but expects a more attractive entry point "down the road."
PAA Plains All American
$31.63

0.973 (3.17%)

10/04/16
MSCO
10/04/16
UPGRADE
MSCO
Overweight
Plains All American upgraded to Overweight from Equal Weight at Morgan Stanley
10/04/16
MSCO
10/04/16
UPGRADE
Target $37
MSCO
Overweight
Plains All American upgraded to Overweight at Morgan Stanley
As previously reported, Morgan Stanley upgraded Plains All American to Overweight from Equal Weight. Analyst Tom Abrams said Plains is attractive given its Permian basin position, dominant gathering market share, and underutilized assets. He expects operating leverage to drive the the next leg up and for increased utilization of the asset base to result in significant EBITDA growth with limited incremental capex.
10/05/16
WELS
10/05/16
UPGRADE
WELS
Outperform
Plains All American upgraded to Outperform from Market Perform at Wells Fargo
Wells Fargo analyst Michael Blum upgraded Plains All American to Outperform on expectations the Permian will lead the recovery in U.S. oil supply growth as global supply/demand tightens. The analyst raised his price target range for the shares to $34-$36 from $28-$31.
09/09/16
FBRC
09/09/16
INITIATION
Target $30
FBRC
Market Perform
Plains All American initiated with a Market Perform at FBR Capital
FBR Capital analyst Robert Balsamo initiated Plains All American with a Market Perform and $30 price target.

TODAY'S FREE FLY STORIES

CNX

CONSOL

$21.30

-0.48 (-2.20%)

, CNNX

CONE Midstream

$21.33

-0.15 (-0.70%)

15:02
12/10/16
12/10
15:02
12/10/16
15:02
Conference/Events
CONE Midstream participates in an analyst and investor day »

Management participates…

CNX

CONSOL

$21.30

-0.48 (-2.20%)

CNNX

CONE Midstream

$21.33

-0.15 (-0.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

CNNX

CONE Midstream

$21.33

-0.15 (-0.70%)

, CNX

CONSOL

$21.30

-0.48 (-2.20%)

14:59
12/10/16
12/10
14:59
12/10/16
14:59
Conference/Events
CONSOL to host analyst and investor day »

Analyst and Investor Day…

CNNX

CONE Midstream

$21.33

-0.15 (-0.70%)

CNX

CONSOL

$21.30

-0.48 (-2.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

BG

Bunge

$73.36

-0.04 (-0.05%)

14:54
12/10/16
12/10
14:54
12/10/16
14:54
Conference/Events
Bunge to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMD

AMD

14:50
12/10/16
12/10
14:50
12/10/16
14:50
Conference/Events
AMD to host Summit Ridge a "Zen"-based CPU at New Horizon »

President & CEO Su…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AJG

Arthur J. Gallagher

$50.76

0.61 (1.22%)

14:41
12/10/16
12/10
14:41
12/10/16
14:41
Conference/Events
Arthur J. Gallagher to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

NYT

New York Times

$14.10

0.15 (1.08%)

14:34
12/10/16
12/10
14:34
12/10/16
14:34
Conference/Events
Detroit Economic Club to hold a luncheon meeting »

Mark Thompson, President…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZN

AstraZeneca

$27.16

0.89 (3.39%)

14:28
12/10/16
12/10
14:28
12/10/16
14:28
Conference/Events
AstraZeneca has a luncheon meeting with Philadelphia Securities Association »

Luncheon Meeting being…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 16

    Feb

CASC

Cascadian Therapeutics

$5.65

-0.03 (-0.53%)

, GHDX

Genomic Health

$30.81

-0.17 (-0.55%)

04:55
12/10/16
12/10
04:55
12/10/16
04:55
Conference/Events
UT Health Science Center to hold a symposium »

2016 San Antonio Breast…

CASC

Cascadian Therapeutics

$5.65

-0.03 (-0.53%)

GHDX

Genomic Health

$30.81

-0.17 (-0.55%)

MYGN

Myriad Genetics

$17.40

0.41 (2.41%)

RDUS

Radius Health

$43.94

-3.13 (-6.65%)

OCX

OncoCyte

$6.15

0.05 (0.82%)

ABBV

AbbVie

$61.54

0.64 (1.05%)

BAYRY

Bayer

$100.04

1.14 (1.15%)

CELG

Celgene

$113.47

0.41 (0.36%)

CLDX

Celldex

$3.75

0.01 (0.27%)

DNA

Bought by RHHBY

HRTX

Heron Therapeutics

$14.90

-0.55 (-3.56%)

PFE

Pfizer

$31.70

0.76 (2.46%)

PBYI

Puma Biotechnology

$36.50

0.05 (0.14%)

TSRO

TESARO

$129.97

-1.57 (-1.19%)

NSTG

NanoString

$21.79

-0.35 (-1.58%)

NVS

Novartis

$69.74

2.15 (3.18%)

NVTA

Invitae

$7.24

0.28 (4.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 11

    Jan

BBSI

Barrett Business

$62.30

1.85 (3.06%)

, BREW

Craft Brew

$16.65

0.45 (2.78%)

04:55
12/10/16
12/10
04:55
12/10/16
04:55
Conference/Events
Roth Capital to hold a conference »

5th Annual ROTH Utah…

BBSI

Barrett Business

$62.30

1.85 (3.06%)

BREW

Craft Brew

$16.65

0.45 (2.78%)

CHKE

Cherokee

$11.10

-0.35 (-3.06%)

DFBG

Differential Brands

$3.20

0.25 (8.47%)

DLA

Delta Apparel

$20.77

-0.39 (-1.84%)

ESCA

Escalade

$13.65

-0.15 (-1.09%)

FLKS

Flex Pharma

$6.29

-0.01 (-0.16%)

KONA

Kona Grill

$12.75

0.05 (0.39%)

LNDC

Landec

$15.05

-0.25 (-1.63%)

MEET

MeetMe

$5.63

0.16 (2.93%)

MITK

Mitek Systems

$6.50

0.35 (5.69%)

MB

MINDBODY

$20.70

-0.25 (-1.19%)

OSIS

OSI Systems

$78.17

1.22 (1.59%)

PLNT

Planet Fitness

$21.01

-0.07 (-0.33%)

ROX

Castle Brands

$0.75

0.0309 (4.30%)

PRTS

U.S. Auto Parts

$3.33

0.09 (2.78%)

RSYS

RadiSys

$4.77

0.11 (2.36%)

SWHC

Smith & Wesson

$21.07

-0.16 (-0.75%)

VSTO

Vista Outdoor

$38.62

-1.24 (-3.11%)

WMAR

West Marine

$9.41

0.13 (1.40%)

ZAGG

ZAGG

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 12

    Dec

  • 13

    Dec

  • 13

    Dec

  • 09

    Jan

ANET

Arista Networks

$94.41

-1.35 (-1.41%)

, CSCO

Cisco

$30.06

0.11 (0.37%)

18:32
12/09/16
12/09
18:32
12/09/16
18:32
Hot Stocks
Arista Networks favored in ITC initial determination on four of six patents »

Arista Networks (ANET)…

ANET

Arista Networks

$94.41

-1.35 (-1.41%)

CSCO

Cisco

$30.06

0.11 (0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 12

    Dec

  • 12

    Dec

TKTDY

Takata Corporation

$10.70

0.05 (0.47%)

18:22
12/09/16
12/09
18:22
12/09/16
18:22
Periodicals
U.S. DOT looks to accelerate pace of Takata air bag replacements, Reuters says »

The U.S. Department of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DV

DeVry

$31.90

0.9 (2.90%)

18:17
12/09/16
12/09
18:17
12/09/16
18:17
Hot Stocks
Breaking Hot Stocks news story on DeVry »

International Value…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

CSOD

Cornerstone OnDemand

$39.10

-0.11 (-0.28%)

18:10
12/09/16
12/09
18:10
12/09/16
18:10
Periodicals
Cornerstone OnDemand considers sale amid activist pressure, Bloomberg reports »

Cornerstone OnDemand has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVM

CEL-SCI

$0.12

-0.0014 (-1.17%)

18:03
12/09/16
12/09
18:03
12/09/16
18:03
Hot Stocks
NYSE MKT says CEL-SCI noncompliant with certain listing requirements »

CEL-SCI reported on a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XOM

Exxon Mobil

$89.00

0.68 (0.77%)

18:01
12/09/16
12/09
18:01
12/09/16
18:01
Periodicals
Exxon CEO Tillerson emerges as top candidate for secretary of state, WSJ says »

Exxon Mobil CEO Rex…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FUL

H.B. Fuller

$50.36

0.05 (0.10%)

17:58
12/09/16
12/09
17:58
12/09/16
17:58
Hot Stocks
H.B. Fuller announces restructuring, to eliminate, relocate 220 positions »

H.B. Fuller has announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIIB

Biogen

$287.77

-1.77 (-0.61%)

17:53
12/09/16
12/09
17:53
12/09/16
17:53
Periodicals
Biogen looks like a bargain, Barron's reports »

Biogen trades at just…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNY

Sanofi

$40.40

0.63 (1.58%)

17:42
12/09/16
12/09
17:42
12/09/16
17:42
Periodicals
Sanofi to lay off 20% of U.S. diabetes, cardiovascular staff, Bloomberg says »

The layoffs include parts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Mar

CSOD

Cornerstone OnDemand

$39.10

-0.11 (-0.28%)

17:38
12/09/16
12/09
17:38
12/09/16
17:38
Periodicals
Cornerstone OnDemand considers sale amid activist pressure, Bloomberg reports »

Investor Praesidium said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TACO

Del Taco

$14.75

-0.39 (-2.58%)

17:34
12/09/16
12/09
17:34
12/09/16
17:34
Hot Stocks
Breaking Hot Stocks news story on Del Taco »

PW Acquisitions cuts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jan

  • 09

    Jan

  • 09

    Dec

UNVR

Univar

$26.36

0.54 (2.09%)

, BXLT

Baxalta

17:30
12/09/16
12/09
17:30
12/09/16
17:30
Hot Stocks
Univar names Eric Foster chief information officer »

Univar (UNVR) named Eric…

UNVR

Univar

$26.36

0.54 (2.09%)

BXLT

Baxalta

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PARN

Parnell

$1.42

-0.0031 (-0.22%)

17:30
12/09/16
12/09
17:30
12/09/16
17:30
Hot Stocks
Breaking Hot Stocks news story on Parnell 

Parnell trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BSX

Boston Scientific

$20.81

0.2 (0.97%)

, NVRO

Nevro

$76.38

-1.88 (-2.40%)

17:24
12/09/16
12/09
17:24
12/09/16
17:24
Hot Stocks
Boston Scientific files patent infringement suit against Nevro »

Nevro (NVRO) announced…

BSX

Boston Scientific

$20.81

0.2 (0.97%)

NVRO

Nevro

$76.38

-1.88 (-2.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

RTN

Raytheon

$146.30

0.14 (0.10%)

17:21
12/09/16
12/09
17:21
12/09/16
17:21
Hot Stocks
Raytheon awarded $101.9M government contract »

Raytheon Co., Goleta,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CX

CEMEX

$8.77

-0.16 (-1.79%)

17:18
12/09/16
12/09
17:18
12/09/16
17:18
Hot Stocks
CEMEX receives subpoena from SEC regarding Foreign Corrupt Practices Act »

On December 9, 2016,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.